Harvest Group Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-289
Closed -$31K 39
2020
Q4
$31K Hold
289
0.02% 141
2020
Q3
$25K Sell
289
-104
-26% -$9.79K 0.02% 150
2020
Q2
$38K Sell
393
-23
-6% -$2.02K 0.03% 98
2020
Q1
$31K Buy
416
+20
+5% +$1.7K 0.03% 100
2019
Q4
$35K Sell
396
-32
-7% -$2.66K 0.03% 103
2019
Q3
$32K Buy
428
+23
+6% +$1.58K 0.04% 106
2019
Q2
$29K Sell
405
-200
-33% -$15.7K 0.04% 108
2019
Q1
$49K Buy
+605
New +$49.5K 0.05% 90

Other funds holding ABBV

Harvest Group Wealth Management's ABBV Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 289 shares — an estimated $31K sold.

Harvest Group Wealth Management first reported a position in ABBV in Q1 2019 and held it in 8 quarters. The position peaked at $49K in Q1 2019. 2,614 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Harvest Group Wealth Management reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • Harvest Group Wealth Management sold 289 AbbVie shares in Q1 2021, an estimated $31K.
  • Harvest Group Wealth Management first reported a position in AbbVie in Q1 2019 and held it in 8 quarters.
  • Harvest Group Wealth Management's AbbVie position peaked at $49K in Q1 2019.
  • 2,614 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.